The content on this site is intended for healthcare professionals only
Dr Terri McVeigh speaks to ecancer about considerations to make when communicating genomic information.
She highlights the inadvertent identification of heritable variants of cancer and the impact of heritable genomic variation.
Dr McVeigh concludes by discussing the communication of genetic and genomic cancer information with patients; how genetic information is inherited and if/how they would disclose the information to their family members.
She adds that it is good practice to forewarn patients that germline variants may inadvertently be identified and further testing may be required.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
